About Us

Patricia Salvati has been the Company’s Vice President, Discovery since she co-founded Newron in 1998 along with Dr. Benatti and Dr. Fariello.  She is a pharmacologist with over 25 years of experience in research and development in the pharmaceutical industry.  After receiving a doctoral degree in biological sciences from the University of Bologna with honours, she underwent post-doctoral training in pharmacology at the University of Pavia, followed by additional training at the University College (London, United Kingdom); Prostaglandin Unit of the Wellcome Research Laboratory (Beckenham, Kent, United Kingdom); New York Medical College (Valhalla, New York, United States); the Biophysics Institute of Aarhus University (Denmark) and Shimane University (Izumo, Japan).  Having gained extensive experience in gastro-intestinal pharmacology and cardiovascular research, she devoted her research to neuropharmacology beginning in 1993.  She holds over 60 patents and is the author of over 90 publications.  Dr. Salvati has extensive experience in leading drug development projects in the industry.  In 1978, she joined Farmitalia Carlo Erba where she became the head of Cardiovascular Pharmacology in 1986 and then the director of Cardiovascular Research in 1990.  After the merger with Pharmacia & Upjohn, she was appointed the head of CNS Pharmacology and Project Leader of the antiepileptic project in 1995 and held that position until she co-founded Newron in 1998 along with Dr. Benatti and Dr. Fariello.